Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment

J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems

NP Staff, JC Fehrenbacher, M Caillaud, MI Damaj… - Experimental …, 2020 - Elsevier
Abstract Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers
like breast, ovarian and lung cancer. Although highly effective in blocking tumor progression …

Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence

SB Park, A Cetinkaya-Fisgin, AA Argyriou… - Journal of Neurology …, 2023 - jnnp.bmj.com
Multiple pathological mechanisms are involved in the development of chemotherapy-
induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the …

Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based …

S Tamburin, SB Park, A Schenone, E Mantovani… - Critical reviews in …, 2022 - Elsevier
Pharmacological strategies for chemotherapy-induced peripheral neurotoxicity (CIPN) are
very limited. We systematically reviewed data on rehabilitation, exercise, physical therapy …

Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies

A Calls, V Carozzi, X Navarro, L Monza, J Bruna - Experimental Neurology, 2020 - Elsevier
One of the most relevant dose-limiting adverse effects of platinum drugs is the development
of a sensory peripheral neuropathy that highly impairs the patients' quality of life. Nowadays …

Non‐length‐dependent small fiber neuropathy: not a matter of stockings and gloves

F Gemignani, MF Bellanova, E Saccani… - Muscle & …, 2022 - Wiley Online Library
The clinical spectrum of small fiber neuropathy (SFN) encompasses manifestations related
to the involvement of thinly myelinated A‐delta and unmyelinated C fibers, including not only …

[HTML][HTML] Bortezomib-induced peripheral neuropathy: clinical features, molecular basis, and therapeutic approach

Y Yang, B Zhao, H Lan, J Sun, G Wei - Critical Reviews in Oncology …, 2024 - Elsevier
Bortezomib is the first-line standard and most effective chemotherapeutic for multiple
myeloma; however, bortezomib-induced peripheral neuropathy (BIPN) severely affects the …

Validity of patient-reported outcome measures in evaluating nerve damage following chemotherapy

T Li, HC Timmins, FM Mahfouz, T Trinh… - JAMA network …, 2024 - jamanetwork.com
Importance Chemotherapy-induced peripheral neuropathy (CIPN) is a substantial adverse
effect of anticancer treatments. As such, the assessment of CIPN remains critically important …

[HTML][HTML] Neurological complications of conventional and novel anticancer treatments

P Alberti, A Salvalaggio, AA Argyriou, J Bruna… - Cancers, 2022 - mdpi.com
Simple Summary Cancer survivors can experience neurological complications after
exposure to anticancer therapy. Chemotherapy-induced peripheral neurotoxicity (CIPN) …

Cutaneous pain in disorders affecting peripheral nerves

CL Stucky, AR Mikesell - Neuroscience letters, 2021 - Elsevier
Our ability to quickly detect and respond to harmful environmental stimuli is vital for our
safety and survival. This inherent acute pain detection is a “gift” because it both protects our …